More PRNewswire
View Older Stories View Newer Stories-
Omnicom to Acquire Interpublic Group to Create Premier Marketing and Sales Company
-
Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
-
Ballard to Supply 8 MW of Fuel Cell Engines to Stadler for Californian Passenger Rail
-
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymp
-
Defense Metals Announces Release Date of its Wicheeda Rare Earth Element Project PFS
-
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
-
Mason Capital Management-Led Consortium Completes Acquisition of CB&I
-
PAINTEQ SECURES GROUNDBREAKING PATENT FOR LINQ® TECHNOLOGY, ADVANCING PRECISION AND EFFICIENCY IN SI JOINT FUSION
-
American bespoke Coaching and Psychiatry practice The Open Sea Institute showcased in new book to celebrate 120 years of Rolls-Royce
-
Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
-
Chandler couple opens Caring Senior Service to bring trusted support and companionship to local families
-
Women in HVACR records largest endowment fund donation to date
-
VERSABANK TRANSITIONS CORE TEAM RESPONSIBLE FOR CANADIAN RECEIVABLE PURCHASE PROGRAM SUCCESS TO LEAD US OPPORTUNITY
-
Perpetua Resources and Sunshine Silver Announce Agreement to Advance Domestic Antimony Supply Chain
-
METALLA ANNOUNCES APPOINTMENT OF CHRIS BEER TO BOARD OF DIRECTORS
-
Apax Funds to Sell Minority Stake in AssuredPartners to Arthur J. Gallagher & Co.
-
LOMOND THERAPEUTICS REPORTS RESULTS FROM ONGOING CLINICAL STUDIES OF LONITOCLAX, A SELECTIVE BCL-2 INHIBITOR WITH BEST-IN-CLASS SELECTIVITY VERSUS BCL-XL AND NO CYP 3A4 LIABILITY
-
GTCR Announces Sale of AssuredPartners to Arthur J. Gallagher & Co. for $13.45 Billion
-
Riot Platforms Announces Proposed Private Offering of $500 Million of Convertible Senior Notes
-
Aircastle Delivers the First of Six 737MAX9 Aircraft to United Airlines
-
Datadog Announces Proposed Private Offering of $775 Million of Convertible Senior Notes
-
VERSABANK DECLARES DIVIDENDS
-
CVS Health Corporation Announces Expiration and Results of Any and All Tender Offer
-
Movement Network Foundation Announces Launch of Movement Mainnet Beta and $MOVE Token Generation Event
-
VERSABANK FOURTH QUARTER AND FISCAL 2024 RESULTS CONTINUE TO DEMONSTRATE STRENGTH OF BUSINESS MODEL AS BANK LAUNCHES PROVEN RPP SOLUTION IN US MARKET
-
Wayfair Professional Unveils 2025 Design Trends
-
Startup World Cup 2025 CES Las Vegas - Win $1M Investment Prize!
-
Lodging Dynamics Hospitality Group Welcomes Hospitality Veteran Lisa Carlson as Chief Operating Office
-
Chorus One Joins Northstake's ETH Validator Marketplace As Node Operator
-
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
-
Sunoco LP Announces 2025 Operational and Financial Guidance and Participation in Upcoming Mizuho Power, Energy & Infrastructure Conference
-
Siyata Mobile's Versatile Bluetooth Remote Speaker Mic Gaining Sales Momentum
-
EARTHDAY.ORG RELEASES THE FIRST-OF-ITS-KIND LIVE TRACKER: MONITORING THE STATUS OF CLIMATE EDUCATION IN NATIONALLY DETERMINED CONTRIBUTIONS (NDCs) ACROSS THE WORLD
-
Hamilton Lane Named a 'Best Place to Work in Money Management' For the 13th Consecutive Year by Pensions & Investments
-
McDermott Completes CB&I Divestment to Consortium of Investors led by Mason Capital Management
-
Simon® to Present at the Goldman Sachs 2024 U.S. Financial Services Conference
-
U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025
-
Arthur J. Gallagher & Co. Announces $8.5 Billion Common Stock Offering
-
NEVADA KING DRILLS MULTIPLE THICK +1 G/T GOLD INTERCEPTS HIGHLIGHTED BY 1.95 G/T AU OVER 29.0M INCLUDING 6.6 G/T AU OVER 6.1M AT NORTH EXTENSION TARGET AT ATLANTA
-
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa
-
Nuvalent Appoints Grant Bogle to Board of Directors
-
TXNM Energy to Meet with Investors
-
Valens Semiconductor Appoints Gili Friedman as Senior Vice President, Head of Cross Industry Business
-
Osage Advisors Advises Falcon Electronics in its Sale to Brevan Electronics
-
VirnetX Announces New Chief Technical Officer
-
Argus launches world's first Greek natural gas prices
-
An AI Crime Surge? 3 in 5 Americans Feel Artificial Intelligence Will Create More Identity Theft in 2025
-
CoinEx 2024 Brand Day Review: Promoting Platform Philosophy and Empowering Users with Diversified Investments
-
Buyback of Class B shares in Essity during week 49, 2024
-
H.I.G. Realty Invests in Second Living Sector Project in Central London
